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Both mechanical and biochemical stimulation are required for maintaining the integrity of articular cartilage.
However, chondrocytes respond differently to mechanical stimuli in osteoarthritic cartilage when biochemical
signaling pathways, such as Insulin-like Growth Factor-1 (IGF-1), are altered. The Transient Receptor Potential
Vanilloid 4 (TRPV4) channel is central to chondrocyte mechanotransduction and regulation of cartilage ho
meostasis. Here, we propose that changes in IGF-1 can modulate TRPV4 channel activity. We demonstrate that
physiologic levels of IGF-1 suppress hypotonic-induced TRPV4 currents and intracellular calcium flux by
increasing apparent cell stiffness that correlates with actin stress fiber formation. Disruption of F-actin following
IGF-1 treatment results in the return of the intracellular calcium response to hypotonic swelling. Using point
mutations of the TRPV4 channel at the microtubule-associated protein 7 (MAP-7) site shows that regulation of
TRPV4 by actin is mediated via the interaction of actin with the MAP-7 domain of TRPV4. We further highlight
that ATP release, a down-stream response to mechanical stimulation in chondrocytes, is mediated by TRPV4
during hypotonic challenge. This response is significantly abrogated with IGF-1 treatment. As chondrocyte
mechanosensitivity is greatly altered during osteoarthritis progression, IGF-1 presents as a promising candidate
for prevention and treatment of articular cartilage damage.

1. Introduction
Articular cartilage homeostasis requires a continuous balance be
tween repair and degradation [3,4]. Loss of this remodeling balance can
lead to degradation of the articular cartilage resulting in osteoarthritis
(OA), the leading cause of disability among American adults [1,2].
Chondrocytes embedded within the extracellular matrix (ECM) of
cartilage contribute to this remodeling process by responding to
biomechanical and biochemical signals to synthesize or breakdown the
ECM [5].
Mechanical forces experienced by chondrocytes can initiate both
catabolic and anabolic activity [6,7] depending on the magnitude and
type of stimuli [8,9]. These actions are mediated, in part, by signaling
pathways that include growth factors and receptors [10,11],

mitogen-activated protein (MAP) kinases [12], Rho guanosine-5′ -
triphosphate (GTP)ases [13], nitric oxide [9,14], integrins [15], and ion
channels [16]. Among these biochemical signals, insulin-like growth
factor-1 (IGF-1) is unusual in that it stimulates both mitogenic and
anabolic functions while inhibiting catabolic activity in articular chon
drocytes [17–20]. Mechanical forces and IGF-1signaling interact to
regulate articular chondrocytes [21–23], however the mechanisms
responsible for this interaction between the two remain unclear.
The mechanosensitive Transient Receptor Potential Vanilloid 4
(TRPV4) ion channel is integral in chondrocyte mechanotransduction
through its regulation of Ca2+influx. TRPV4-mediated Ca2+ influx reg
ulates SOX9 expression [24], a key transcription factor involved in
cartilage matrix synthesis. TRPV4 mediates the cellular response to
changes in osmolarity [25–27] and mechanical stimulation [28–31],
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both of which are integral in cartilage integrity. The importance of the
TRPV4 channel to cartilage homeostasis is illustrated by targeted dele
tion of TRPV4 in mice that results in severe joint damage resembling
osteoarthritis and a loss of sensitivity to osmotic swelling [32]. How
ever, the mechanism through which biochemical signaling and biome
chanical stimuli influence TRPV4 gating remains unknown.
Chondrocyte stiffness has been shown to be significantly greater in
chondrocytes isolated from OA cartilage than those isolated from
normal articular cartilage [33]. However, it remains unclear what cau
ses the changes in cell stiffness and how such changes influence cellular
responses to mechanical stimuli. We have reported that osteoblasts
subjected to fluid shear stress (FSS) increase the polymerization of
F-actin through activation of RhoA GTPase that, in turn, increases the
stiffness of the cell [34]. Previous studies suggest IGF-1 also increases
cell stiffness and F-actin formation in chondrocytes [35] and this in
crease in F-actin by IGF-1 results from activation of a Rho GTPase [18].
We have also shown that actin organization regulates the activity of the
mechanosensitive channels in osteoblasts [36]. Thus, IGF-1 may regu
late TRPV4 activity in chondrocytes via reorganization of the actin
cytoskeleton.
Suzuki et al. suggest that the TRPV4 channel is regulated through
binding of F-actin to the Microtubule Associated Protein Binding 7
(MAP7: amino acids 798–809) domain of TRPV4 [37]. We previously
reported that two point mutations within this domain (P799L and
G800D) results in metatropic dysplasia, a severe skeletal dysplasia, in
children [39]. These mutations cause a gain of function of the TRPV4
channel which alters chondrogenesis and chondrocyte intracellular
calcium influx in human chondrocytes. This effect may be influenced by
altering the regulation of the TRPV4 channel by the actin cytoskeleton.
By leveraging these novel mutations, we highlight the role of the MAP7
binding in regulation of the TRPV4 channel during IGF-1 treatment.

extracellular-like solution (ECF) composed of (in mM): NaCl 150, CsCl
6, MgCl2 1, CaCl2 5, HEPES 10 and glucose 10, titrated to pH 7.4 with
CsOH (total osmolarity 320mOsm). Pipettes were filled with an
intracellular-like solution (ICF) containing (in mM): CsCl 20, CsAs
partate 100, MgCl2 1, HEPES 10, Mg2ATP 4, CaCl2 0.08 and BAPTA 10,
titrated to pH 7.4 with CsOH. Cesium was used in both the bath and
pipette solutions to prevent activation of potassium currents [38].
Whole cell recordings were performed at room temperature with an
Axopatch 200B amplifier (Axon Instruments, USA) equipped with a
Digidata 1332A A/D converter. Recordings were made using a ramp
protocol that clamps the cell at 0 mV, then ramps the membrane voltage
from − 80 mV to +80 mV over 1000 ms. The cell then is returned to 0 mV
for 12.5 s prior to restarting the protocol. Data were collected on an IBM
compatible PC using pClamp version 10.0 software (Axon Instruments).
To determine the effect of hypotonic swelling (HS) on TRPV4 whole
cell currents, the ECF was diluted to approximately 110 mOsm (75%
change in osmolarity), perfused into the patch chamber and changes in
whole cell current recorded using the same ramp protocol as described
above. To determine if the TRPV4 channel was responsible for the cur
rents induced by hypotonic swelling, cells were pre-incubated with 10
µM RN-1734 (Sigma), a specific inhibitor for TRPV4 channels, for 15
min prior to swelling. To determine the effects of IGF-1 on TRPV4
channel activity, the cell medium was replaced with reduced serum
media supplemented with 300 ng/mL IGF-1 (human recombinant,
Sigma) for 3 h. Electrophysiology measurements were then performed to
determine if IGF-1 pretreatment altered TRPV4 currents induced by
hypotonic swelling. All experiments were performed at room tempera
ture to avoid the influence of TRPV4 activation at physiological
temperatures.
2.4. Mechanical stimuli and pharmacological treatment for actin
immunofluorescence

2. Material and methods

ATDC5 cells were subjected to hypotonic swelling (HS) by adding
equal volume of water. Cells were pre-treated with 300 ng/ml IGF-1 for
3 h prior to HS or pre-treated for 10 min with the general TRPV channel
inhibitor, ruthenium red (RR, 10 μM) or with the TRPV4-specific in
hibitor, RN-1734. The concentrations of IGF-1, ruthenium red, and RN1734 were maintained during HS. To determine the role of cytoskeleton
organization on mechanosensitivity following IGF-1 treatment, cells
were treated with 1 μM cytochalasin D for 30 min prior to HS in both
IGF-1 treated and un-treated control cells. ATDC5 cells were washed
with PBS for 5 min and then fixed in 4% paraformaldehyde (Electron
Microscopy Sciences, PA, USA) in PBS containing 0.1% Triton X-100
(Sigma) for 30 min on ice. Cells were then washed with PBS and incu
bated with blocking buffer containing 3% BSA (Sigma) at room tem
perature for 1 hr, and then incubated with Alexa Fluor® 488 phalloidin
(1:1000, Life Technologies, Grand Island, NY), mounted using the
SlowFade® Antifade kit (Life Technologies) and imaged on a Zeiss
LSM710 laser scanning confocal microscope with a 63X oil immersion
lens at the midplane of the cells.

2.1. Clinical information
Patients were recruited from the Skeletal Dysplasia Program at
Alfred I. duPont Hospital for Children (AIDHC) in Wilmington, Dela
ware, under a Nemours IRB-approved protocol. Metatropic dysplasia
was diagnosed based on clinical evaluation and radiographic
information.
2.2. Culture of ATDC5 and HEK293 cells
ATDC5 mouse chondrocyte-like cells (Sigma-Aldrich, St. Louis, MO)
were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Sigma),
10% FBS (Gibco, New York, NY), 100 U/ml penicillin G, and 100 μg/ml
streptomycin (P/S, Mediatech, Manassas, VA). HEK 293 cells that were
un-transfected (UT) or transfected with either wild-type TRPV4 (WT), a
proline to leucine mutation at the 799 amino acid of TRPV4 (P799L), or
a glycine to aspartate mutation at the 800 amino acid of TRPV4 (G800D)
were grown in Minimal Essential Media (MEM, Corning) supplemented
with 10% FBS and 1% P/S. Cells were maintained in a humidified
incubator at 37 ◦ C with 5% CO2/95% air and passaged once cells
reached 75% confluence. Before all experiments, cells were serum
starved in reduced serum media (0.2% FBS, 1% P/S).

2.5. Atomic force microscopy
The apparent stiffness of individual cells was measured using an
Atomic Force Microscope (AFM: BioScope II, Veeco Inc., Plainview, NY)
mounted on an inverted optical microscope. Soft microlever probes
(MLCT-AUNM, Veeco Inc.) with a conical tip having a spring constant of
0.01 N/m were first calibrated using a thermal fluctuation method in
fluid. An area of 30 μm x 30 μm was first scanned at a speed of ~3 μm/
sec to generate a topographic map of an individual cell. Seven to ten
points were then selected over the cell body at the nuclear and per
i‑nuclear regions for indentation measurements. Cell membranes were
indented at a speed of ~2.5 μm/sec until a force of 100 pN was reached,
which typically resulted in an indentation depth of < 70 nm (10% of the
cell height). The elastic modulus at each point was estimated from the

2.3. Electrophysiological recordings
ATDC5 cells were cultured in DMEM with 10% FBS and 100 U/ml
penicillin G, and 100 μg/ml streptomycin on 15 mm round coverglass
(Ted Pella, Inc., Redding, CA). Pipettes were manufactured by pulling
100 μL capillary tubes (VWR, Arlington Heights, IL) to a tip diameter of
~0.5 µm (tip resistance = 1–5 MΩ) using a dual-stage pipette puller
(Narishige, East Meadow, NY). Pipettes were flame polished and coated
with wax to reduce capacitance artifacts. Cells were bathed in an
2
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recorded force-deflection curve using a Hertz based model as defined by
the following:
E=

2F(1 − υ2 )
π δ2 tan(φ)

2.8. Generation and validation of HEK293 cells expressing wt and mutant
TRPV4
2.8.1. Total RNA preparation
Human fibroblast cells (from individuals known to express WT,
P799L, and G800D variants) were grown to approximately 50%
confluence and RNA was isolated using TRIzol Reagent (Invitrogen)
following the manufacturer’s instructions.

(1)

where E is the apparent stiffness, F is the cantilever force measured by
the AFM, υ is the Poisson ratio of the cytoplasm (υ = 0.4) [40], φ is the
opening angle of the conical cantilever tip (φ = 35◦ ). The indentation
depth (δ) was calculated by subtracting the cantilever deflection from
the piezo displacement of the probe. The apparent stiffness for a given
cell was defined by the average elastic modulus across each point
measured. A total of 5 to 6 cells were measured following a given
treatment, and each experiment was then repeated 3 times. The average
cell stiffness for each treatment was compared to static controls and
reported as a fold increase. Static controls were not subjected to any
form of treatment or mechanical stimuli.

2.8.2. RT-PCR
ProtoScript II Reverse Transcriptase and the First Strand cDNA Syn
thesis Kit (NEB) were used to make cDNA per the manufacturer’s in
structions. Each reaction used 0.5 µg of total RNA, 500 µg oligo(dT)
(Agilent) and 0.5 µl RNaseBlock (Agilent). The TRPV4 coding sequence
was amplified by PCR using the following gene specific primers:
forward
primer
5′ -CAAAGGAGGTACCCACCATGGCGGATTCCA
′
reverse
primer
5′ -AGGAGGAGACAACTTCTAGATCA
GCGA-3 ,
GAGCGGGGCGTCATCAGT-3′ . The underlined sequences are found in the
TRPV4 CDS. PCR was performed using Q5® High-Fidelity DNA Poly
merase (NEB) with GC enhancer, per the manufacturer’s instructions. The
reaction was amplified for 35 cycles using the following settings: dena
turation - 98 ◦ C for 10 s, annealing - 65.7 ◦ C for 30 s, extension - 72 ◦ C for
120 s. The PCR product was then purified using the SV gel and PCR
Cleanup Kit (Promega).

2.6. Calcium imaging
ATDC5 cells and HEK cells were washed with Hanks’ balanced saline
solution (HBSS, Sigma) before being loaded with fluorescent Ca2+ in
dicators (3 μM of fura-2 AM or 5.69 μM of Fluo-4 AM, Life Technologies)
in HBSS for 30 min at 37 ◦ C. The cells were rinsed with HBSS and
incubated at room temperature for 15 min in HBSS. Using fura-2AM,
changes in [Ca2+]i were recorded using a ratiometric video-image
analysis apparatus (Intracellular Imaging, Cincinnati, OH, USA) on a
Nikon inverted microscope with a Nikon 30 × fluor objective. The ratio
of emitted light at 340 and 380 nm excitation was determined from
consecutive frames and used to determine the [Ca2+]i of selected cells
based on previous calibration of known standards. When loading cells
with Fluo-4 AM, fluorescence was measured every 500 ms on a Zeiss 5
Live DUO Highspeed Confocal with a 10 × /0.3A water immersion
objective. For all experiments, a baseline of [Ca2+]i or relative fluores
cence were first recorded for 1 min, after which HS was applied. The
influence of IGF-1 on the [Ca2+]i response was determined by treating
either ATDC5 or HEK WT and TRPV4 mutant cells with 300 ng/ml of
IGF-1 for 3 h prior to loading with fura-2AM or Fluo-4AM. To determine
how different doses of IGF-1 influence ATDC5s 0, 1, 100, and 300 ng/ml
were added to the cells for 3 hr before challenging with HS. Time course
studies of 300 ng/ml IGF-1 treatment on ATDC5 cells were completed
with pretreatment times of 0, 30, 60, 120, and 180 min prior to loading
with fura-2 AM. For a subset of experiments, the cytoskeleton was dis
rupted by treating ATDC5 cells with 5 µM of cytochalasin D for 30 min
prior to HS. Imaging was performed at room temperature to avoid the
influence of physiological activation of TRPV4.

2.8.3. Gibson cloning
Gibson Assembly reactions were performed using the Gibson As
sembly Cloning Kit (NEB). ~ 75 fMol of insert was combined with ~25
fMol of vector and incubated for 15 min at 50 ◦ C. Then 5-alpha
Competent E. coli (High Efficiency) (NEB) were transformed, per the
manufacturer’s instructions. After outgrowth in SOC, cells were plated
onto LB agar plates containing Kanamycin. The plates were incubated
overnight, and colonies were selected for further analysis.
2.8.4. Vector preparation
One µg of the vector pSF-CMV-EMCV-NEO was digested in a 20 µl
reaction with 1 µl each of XbaI and NcoI (FastDigest enzymes, Fer
mentas) in 1X FastDigest Green Buffer (Fermentas). The reactions were
electrophoresed on a 0.8% agarose gel using TAE buffer. The bands that
corresponded to the double digested vector were gel purified using the
SV gel and PCR Cleanup Kit (Promega).
2.8.5. Plasmid preparation
Individual E. coli colonies were selected and added to LB broth and
shaken vigorously at 37 ◦ C overnight. Then 1000 μL of each sample was
centrifuged for 1 min at RT. The precipitate was resuspended in ice-cold
GTE buffer (50 mM glucose, 25 mM Tris, 10 mM EDTA). RNAse A was
added to each sample to a final concentration of 100 μg/mL. Next, SDS/
NAOH lysis solution (1% SDS and 0.2 M NaOH) was added, and the
samples were rapidly inverted. The suspension was chilled for 5 min.
Each tube then received ice-cold Potassium Acetate/Acetic acid
neutralizing solution. Tubes were centrifuged for 4 min, and an equal
volume of chloroform was added to each solution to make a 1:1 final
concentration. Next, isopropanol was added to each sample and the
tubes were incubated at room temperature for 2 min. Tubes were
centrifuged for five minutes (4 ◦ C at 10,000 g), the precipitate was then
washed with 95% ethanol and the samples were centrifuged again.
Finally, each pellet was suspended in TE buffer (10 mM Tris and 1 mM
EDTA).

2.7. ATP assay
Purinergic signaling in response to mechanical loading has a large
influence on the metabolism of chondrocytes. The release of ATP was
measured from media samples extracted 5 min after the onset of HS to
chondrocytes. The ATP concentration of each sample was measured
using the ATP Bioluminescence Assay kit HTS II (Roche). Emitted light
was measured using a 96 well micro-injector plate reader (POLARstar
OPTIMA, BMG LABTECH GmBH). To normalize the measured ATP
release to cell protein, the ATDC5 cells were washed with PBS imme
diately after HS, and then incubated at − 20 ◦ C with lysis buffer. The
protein samples were stored at − 80 ◦ C for further analysis. The protein
concentration of each sample was determined using a BCA assay (BCA
Protein Assay Kit, Pierce, Rockford, IL) and the 96-well micro-injector
plate reader.

2.8.6. Diagnostic digestion
Identification of mutant and wild type TRVP4 expression was
accomplished by digestion with restriction enzyme SmaI (NEB). Diges
tion with SmaI was accomplished according to the manufacturer’s
instructions.

3
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2.8.7. Transfection
HEK 293 cells were seeded at 8000 − 10,000 cells/cm2 on type 1
collagen (10 µg/cm2, Sigma-Aldrich) coated 35 mm polystyrene dishes
(Falcon) and were cultured overnight in MEM (Corning) with 10% FBS
and 1% P/S. Transfection was accomplished using unsupplemented
MEM media and Lipofectin (Life Technologies), per the manufacturer’s
instructions. Cells were incubated for 24 hr at 37 ◦ C in 5% CO2/95% air.
Following this incubation, the transfection mixture was replaced with
growth media and cells were grown for an additional 48 hr before being
replaced with growth media supplemented with 200 µg/ml G418 sulfate
(Gibco). Cells were cultured for an additional 48 h before being plated as
single cells in a 96-well plate (Corning). Colonies were cultured for 4
days before transferring to T25 flasks (Corning) and grown until 70%
confluent.
2.8.8. DNA sequencing
Samples and primers were prepared and sent to the University of
Delaware Sequencing & Genotyping Center for BigDye sequencing
(LifeTechnologies). Each of the samples were provided at a concentra
tion of 50 μg/μL. Six samples were supplied for testing and three sets of
primers were prepared. The first primer set, forward: 5′ - CCT ACC ATC
CAC TCG ACA CA – 3′ , reverse: 5′ - CGC TTT GCT TTT GGC ATA TC – 3′ .
The second primer set, forward: 5′ - CCC CAT CCT CAA AGT CTT CA – 3′ ,
reverse: 5′ - GCA TGT TGA GGA GCA C – 3′ . The third primer set, for
ward: 5′ - GGG GGC TAC TTC TAC TTT GG – 3′ , reverse: 5′ - CAG GTA
GAG GGC TGC TGA GA – 3′ .
2.9. Statistical analysis
The change in cell stiffness and ATP release was reported as the
average ± SD fold increase relative to static controls unless otherwise
stated. Significance between groups was determined using one-way or
two-way analysis of variance (ANOVA) with a Tukey posthoc test to
determine significance when multiple comparisons in the study were
made. Significance was defined by a p-value < 0.05. Data for a given
outcome measurement was pooled together in the case that no signifi
cant difference was found for a given treatment between different pas
sages of cells.

Fig. 1. TRPV4 channel activity is altered in the presence of IGF-1. A)
Representative IV curve ATDC5 cells during a voltage ramp conducted from
− 80 mV to +80 mV that were challenged with hypotonic swelling (HS, red)
after treatment with the IGF-1 (300 ng/mL) for 3 h (blue), or static controls
(gray). Current was greatly reduced when cells were pretreated with IGF-1. B)
Mean whole cell conductance of TRPV4 in nS is shown during a voltage ramp
from − 80 mV to +80 mV. Cells were static controls (black), untreated cells
(gray), or cells pretreated with IGF-1 (light gray) or the TRPV4 antagonist,
RN1734 (10 µM, white) for 15 min, before challenging with HS. IGF-1 treat
ment and inhibition of TRPV4 completely abolished the conductance in cells
through TRPV4 when compared to cells challenged with HS alone. (TukeyKramer; *** indicates p-value is < 0.001 in comparison to all other conditions,
error bars = ±SEM).

3. Results
3.1. TRPV4 channel activity is suppressed in the presence of IGF-1

3.2. Actin stress fiber formation and cell stiffness

To determine the effects of IGF-1 on TRPV4 channels in ATDC5 cells,
changes in whole-cell currents were determined when the patch clamp
voltage was ramped from − 80 mV to +80 mV (Fig. 1A). Because ex
periments were conducted at room temperature, the temperaturesensitive TRPV4 channels exhibited very little current in response to
the ramp protocol in control cells. However, when the cells were sub
jected to hypotonic swelling (HS), currents were increased. Pretreat
ment of the cells with 300 ng/ml IGF-1 for 3 h prior to the patch,
completely inhibited the HS effects on whole cell currents. Conductance
of the TRPV4 channel was calculated from the slope of the current/
voltage (I/V) relationships under static conditions, HS or pretreatment
with either IGF-1 or the TRPV4 inhibitor, RN1734. The average
conductance changes of the channel in response to these treatments are
shown in Fig. 1B. Hypotonic swelling increased the conductance of the
TRPV4 channel almost 10-foldover that of static control cells (HS vs.
static control: 3.65 nS ± 1.32 vs. 0.36 nS ± 0.06, ±SEM). Both IGF-1 and
RN1734 completely blocked the increase in conductance in response to
HS (0.36 nS ± 0.14 and 0.21 ± 0.17, respectively. These data indicate
that the swelling activated currents are mediated by activation of the
TRPV4 channel and that IGF-1 significantly reduced this response of the
channel to mechanical stimulation.

The cytoskeleton is known to contribute to the mechanical behavior
of chondrocytes, specifically cell stiffness [35], which can greatly in
fluence mechanotransduction. IGF-1 increased actin stress fiber forma
tion (ASFF) in ATDC5 cells as early as 2 h after treatment (Fig. 2A). In
addition, IGF-1 changed ATDC5 cell morphology to a flattened, elon
gated shape with stellate processes. ASFF appeared to peak after 3 h of
treatment with IGF-1 and was associated with ~ 4-fold (12 kPa) increase
in cell stiffness compared to static untreated controls (3.5 kPa) (Fig. 2B).
The increase in cell stiffness due to IGF-1 was dependent on F-actin
based on the decrease in cell stiffness following disruption of the actin
cytoskeleton with cytochalasin D treatment (Fig. 2B).
3.3. TRPV4 channel mediated calcium response
One of the earliest responses to mechanical loading in chondrocytes
is an influx of calcium into the cell that, in turn, initiates signaling
cascades through a wide range of different intracellular pathways [65].
When subjecting ATDC5 cells to HS, we a found a significant increase in
the number of cells exhibiting a calcium response, defined as a 50%
increase in [Ca2+]i above baseline, as well as a significant increase in the
magnitude of the [Ca2+]i response (Fig. 3). To determine if TRPV
4
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Fig. 2. IGF-1 increases actin stress fiber
formation and cell stiffness among ATDC5
cells. A) Time course of IGF-1 treatment in
dicates an increased stress fiber formation
(white arrows) and cell spreading after 1 hour,
with the peak amount occurring after 3 h of
treatment. Bar indicates 50 µm. B) Apparent
cell stiffness of ATDC5 cells was significantly
higher after 3 h of treatment with IGF-1. The
increased stiffness due to IGF-1 was dependent
on F-actin organization based on the decrease
in cell stiffness following cytochalasin D. (* in
dicates p-value is < 0.05 compared to controls).

Fig. 3. The [Ca2þ]i response to HS is mediated through
TRPV4 channel. A) The number of cells responding and B) the
change in [Ca2+]i as a percentage of baseline when ATDC5
cells were treated with 10 µM ruthenium red prior to and
during hypotonic swelling (HS + RR) in order to inhibit all
TRPV channels. Similar results were observed when only
TRPV4 was inhibited by treating ATDC5 cells with 10 µM
RN1734 prior to and during hypotonic swelling (HS + RN). (*
indicates p-value < 0.05 compared to controls, error bars = ±
SEM).

channels mediate the [Ca2+]i response to HS, ATDC5 cells were
pre-treated with the general TRPV inhibitor, ruthenium red (RR). This
non-specific inhibition of TRPV channels significantly decreased both
the number of cells that responded to HS and the magnitude of the
[Ca2+]i response to HS (Fig 3). Addition of RN1734 attenuated the
number of cells responding and magnitude of [Ca2+]i response to HS to
the same degree as ruthenium red.

stimulation, reversed the IGF-1-induced loss in mechanosensitivity,
increasing both the number of responding cells and the magnitude of the
[Ca2+]i response when compared to chondrocytes treated with IGF-1
alone. To determine the optimal dose of IGF-1 that suppresses TRPV4
activity, ATDC5 cells were treated with either 0, 1, 10, 100, or 300
ng/ml of IGF-1 for 3 h prior to mechanical stimulation with HS. IGF-1 at
a concentration of 100 ng/ml and above significantly reduced the
magnitude of the [Ca2+]i response (Fig 4C). To determine the optimal
time of IGF-1 treatment, a time course of 0, 30, 60, 120 and 180 min was
used when cells were treated with 300 ng/ml of IGF-1. A significant
attenuation in the response to HS was achieved within 1 hour of treat
ment and sustained over 3 h of IGF-1 pretreatment (Fig. 4D).
We next sought to determine if the MAP7 binding domain of TRPV4
(aa. 798–809) is responsible for actin dependent regulation of TRPV4.
We previously described how a novel mutation at aa. 800 and a previ
ously known mutation at aa. 799, both within the MAP7 binding domain
of TRPV4, alter TRPV4 mediated calcium kinetics, resulting in Meta
tropic Dysplasia [39]. By cloning the wild-type and mutant TRPV4
variants from these Metatropic Dysplasia patients, we created stably
transfected HEK293 cells that express either wild-type TRPV4 (WT) or
TRPV4 with mutations within the MAP7 binding domain (P799L or

3.4. IGF-1 alters mechanosensitivity through actin cytoskeletal
polymerization via actin’s interaction with TRPV4 at the MAP7 binding
domain
Increases in cell stiffness induced by actin cytoskeletal polymeriza
tion exert a large influence on the sensitivity of cells to mechanical
stimuli [34,41]. To determine if IGF-1 down-regulates channel activity
during mechanical loading (Fig 1) by increasing ASFF (Fig 2), ATDC5
cells were pretreated with 300 ng/ml of IGF-1 for 3 hrs prior to appli
cation of mechanical stimulation with HS (Fig. 4A and B). IGF-1 pre
treatment significantly reduced both the number of cells responding to
HS and the magnitude of the [Ca2+]i response to this stimulation.
Addition of 1 µM of cytochalasin D (Cyto-D) five minutes before HS
5
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Fig. 4. The [Ca2þ]i response to HS is altered
by IGF-1 treatment and actin cytoskeleton
organization. A. Representative [Ca2+]i traces
for cells challenged with hypotonic swelling
(blue) only or during 300 ng/ml IGF-1 treat
ment (gray), IGF-1 + cytochalasin D (black),
and cytochalasin D alone (light blue, Cyto-D).
B) The number of cells responding to HS with
a 50% or greater increase in [Ca2+]i compared
to baseline was significantly attenuated
following IGF-1 treatment. C) The change in
[Ca2+]i compared to baseline in response to HS
was significantly reduced following IGF-1
treatment. Disruption of the F-actin organiza
tion with 1 µM of cytochlasin D (Cyto-D) for 30
min after cells were treated with IGF-1
increased the number of cells exhibiting a
[Ca2+]i response to HS and magnitude in
response. D) [Ca2+]i of a dose response of
ATDC5 to IGF-1 pre-treatment for 3 hr prior to
challenge with 50% HS. Significant attenuation
of [Ca2+]I during hypotonic challenge occurs at
concentrations of 100 ng/ml and 300 ng/ml of
IGF-1. E) Attenuation of [Ca2+]i when ATDC5
cells are challenged with HS starts within 60
min of IGF-1 treatment and is sustained over a
180 min period. (* indicates p-value < 0.05
compared to controls).

G800D). Stable TRPV4 expression in fibroblasts from human patients
with mutations at either the 799 (P799L) or 800 (G800D) amino acids
was confirmed using RT-PCR (Fig. 5A). We validated that WT and or
mutant TRPV4 variants were cloned into the pSF-CMV-EMCV-daGFP
plasmid, using SmaI digestion. The SmaI enzyme specifically cuts at
specific sites with the given sequence: 5′ -CCCGGG-3′ . The WT TRPV4
coding sequence contains this specific sequence at the nucleotide posi
tions 2397 – 2402, whereas the P799L and G800D mutants have the
sequence 5′ -CCTGGG-3′ and 5′ - CCCGGA-3′ at this site, respectively.
Thus, SmaI digests the WT variant transcript of TRPV4, resulting in the
two fragments (Fig 5B). However, the P799L and G800D mutants lack
this cut site, meaning that the enzyme does not fragment these variants.

After transfecting the HEK293 cells with one of the three TRPV4 vari
ants, the expression of functional TRPV4 channels was confirmed.
Pharmacological activation of TRPV4 with 500 nM RN1747, a TRPV4
specific agonist, elicited an increase in [Ca2+]i in HEK cells expressing
WT TRPV4. RN1747 failed to elicit a response in untransfected (UT)
HEK cells, which do not endogenously express TRPV4 (Fig. 5C).
To test if IGF-1 regulates TRPV4 via the MAP7 binding domain of the
channel, HEK cells expressing WT, P799L, or G800D TRPV4 variants and
UT cells were pretreated with 300 ng/ml of IGF-1 for 3 h, prior to
challenge with HS. IGF-1 pretreatment significantly attenuated the
magnitude of [Ca2+]i of the HEK WT cells (Fig. 5D). UT cells demon
strated a significantly lower [Ca2+]i in response to HS when compared to
6
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Fig. 5. MAP7 Binding Domain mediates the response of
HEK cells expressing WT, P799L, and G800D TRPV4 vari
ants to IGF-1 treatment. A) RT-PCR of mRNA from fibroblast
expressing P799L and G800D TRPV4 mutations indicates that
these cells stably express transcripts for mutant TRPV4. B)
pSF-CMV-EMCV-daGFP plasmids containing WT, P799L, and
G800D TRPV4 were successfully generated. SmaI digestion of
WT, P799L, and G800D TRPV4 plasmids results only in
cleavage of the WT TRPV4 clone (fragment ~2000 bp). Mu
tations in the sequence of the P799L and G800D TRPV4 clones
reside within the SmaI cleavage sequence, inhibiting enzy
matic digestion of these clones by SmaI. D) Calcium imaging
of HEK UT (orange) and HEK WT (blue) cells. When HEK UT
and HEK WT cells are treated with the TRPV4 specific agonist
RN1747 (500 nM) only HEK WT cells show elevated [Ca2+]i.
This confirms the presence of functional TRPV4 protein in the
HEK WT cells. Calcium traces represent the average of indi
vidual cells of HEK UT (n = 77) or HEK WT (n = 79). D) The
change in [Ca2+]i compared to baseline in response to HS ±
300 ng/ml of IGF-1 in HEK 293 cells that were either UT or
stably transfected with either WT TRPV4, a mutation of pro
line to lysine at aa. 799 (799) TRPV4, or a mutation of glycine
to aspartate at aa. 800 (800) TRPV4. IGF-1 (black bars)
treatment fails to suppress the response of cells to HS in the
799 and 800 cells. (* indicates p-value < 0.05 compared
across all groups).

the WT cells. This indicates that TRPV4 predominantly mediates the
response of the transfected HEK cells to hypo-osmotic pressures.
Furthermore, UT cells exhibited no attenuation of the [Ca2+]i signal
during IGF-1 pretreatment. IGF-1 pretreatment significantly reduced
[Ca2+]i of WT transfected HEK cells compared to WT controls during HS
and were not significantly different from UT cells. This suggests that IGF-

1 blocked the response to HS in a similar manner to cells completely
lacking TRPV4. The MAP7 binding domain of TRPV4 appears to be
essential for regulation of the channel during IGF-1 treatment since IGF1 pretreatment failed to attenuate [Ca2+]i in the cells expressing either
of the TRPV4 mutants (Fig. 5D). P799L (799) cells responded similarly
to HS, regardless of treatment with IGF-1. Interestingly, IGF-1
7

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on December 28, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

N. Trompeter et al.

Cell Calcium 99 (2021) 102467

pretreatment appears to sensitize HEK G800D (800) cells to HS when
compared to the WT control (Fig. 5D). These results highlight the
importance of the MAP7 domain in regulating TRPV4 activity during
IGF-1 treatment.

regulation of anabolic cell functions [58], suppression of
pro-inflammatory responses [59] and participation in development of
OA [60]. Piezo 1/2 channels were first characterized in 2010 [61] and
are also expressed in many mechanosensitive tissues. Piezo 1 has been
shown to respond to high levels of strain [75,62] however, Piezo 2 ap
pears to be necessary for the full response to mechanical stimulation.
Inhibition of these channels with GsMTx4 reduced chondrocyte
apoptosis, suggesting that these channels may be important to the injury
response in cartilage. While it is apparent that the roles of these channels
in mechanotransduction in the chondrocyte are intertwined, we focused
these studies on the TRPV4 channel due to the response of the channel to
physiologic levels of load.
In these studies, we used osmotic challenge to stimulate the TRPV4
channel because degradation of proteoglycans during OA increases
cartilage hydration through changes in the local osmotic pressure gra
dients, with swelling of cartilage representing one of the earliest
macroscopic events during OA [49–51]. During OA, chondrocytes are
unable to deform their membranes and experience impaired cell volume
regulation [51,52]. Thus, elucidating how decreasing concentrations
and/or insensitivity to IGF-1 in cartilage influences cartilage homeo
stasis may improve therapeutic targeting of OA
This study elucidates a novel mechanism by which IGF-1 interacts
with TRPV4 channel to regulate the mechanical response of the chon
drocyte. Specifically, our results indicate that IGF-1 increases cell stiff
ness through increased stress fiber formation of the actin cytoskeleton
and thereby suppresses the activation of TRPV4 channels in response to
osmotic stimuli. Several reports have suggested that actin and micro
tubules may be closely associated with this channel [37,44,45]. Perhaps
the strongest indication that actin regulates this channel is that when
actin is depolymerized, the osmotic response of the cell is lost [37,44].
Suzuki, et al. have shown the Microtubulin Associating Protein 7
(MAP7) domain at the amino acid sequence 798–809 of TRPV4 interacts
with actin, but not microtubules, to regulate channel activity [37]. Our
results confirm Suzuki’s finding that actin interacts with the MAP7
domain of TRPV4. Moreover, we show that IGF-1 suppresses TRPV4
activity via the MAP7 domain of the channel. When mutations in the
MAP7 domain are expressed in HEK cells, we show that IGF-1 fails to
suppress TRPV4 mediated [Ca2+]i and stimulates the response of G800D
cells to HS. We hypothesize this attenuation in [Ca2+]i is caused by IGF-1
stimulating F-actin, which interacts with the MAP7 domain to modulate
TRPV4 channel kinetics.
IGF-1 is normally located in the local matrix around chondrocytes,
where it is available at relatively constant levels and signals to the cell to
increase anabolic activity and for production of matrix molecules [46].

3.5. IGF-1 alters chondrocyte purinergic signaling
Purinergic signaling in response to mechanical loading is a vital
component of the mechanotransduction pathway of chondrocytes [42,
43]. In response to HS, ATDC5 cells exhibited a significant release of
ATP 5 min after hypo-osmotic challenge (Fig 6A). This ATP release was
significantly attenuated by pretreatment with IGF-1 for 3 h, but was fully
restored when the actin cytoskeleton was disrupted using cytochalasin
D. In addition, the general TRPV4 inhibitor, ruthenium red, or the
TRPV4 specific inhibitor, RN1734, attenuated this response (Fig. 6B) to
similar levels as IGF-1 treatment. These data suggest that IGF-1 sup
presses ATP release during osmotic challenge via the interaction of actin
and TRPV4.
4. Discussion
Both mechanical forces and biochemical factors regulate chon
drocyte function and cartilage integrity. Mechanical loading of cartilage
through exercise and physical therapy has been shown to enhance joint
health in adults [66,67], relieving pain and improving joint mobility in
OA patients [68–70]. This mechanical loading of the joint imposes
several types of mechanical forces at the cellular level such as hydro
static pressure, compressive and tensile strain, fluid shear and osmotic
pressure suggesting mechanotransduction occurs at the membrane of
these cells. Membrane structures such as ion channels, integrins and the
primary cilium have all been associated with mechanotransduction in
the chondrocyte [71]. However, transduction of mechanical signals into
biochemical responses within the cell are complex and it is likely that
different proteins can sense different types of mechanical signals.
Extracellular calcium influx is central to the response of cells to
mechanical loading [72,73]. While several channels are expressed in
chondrocytes that could affect calcium signaling, two types of mecha
nosensitive channels, TRPV4 and PIEZO 1 & 2, have been identified in
chondrocytes and preferentially conduct calcium [74]. TRPV4 channels
are expressed in a myriad of tissues and respond to low levels of me
chanical stimulation such as osmotic pressure and membrane stretch,
although it has been proposed that this channel may interact with other
mechanosensors that could activate the channel [65]. In chondrocytes,
TRPV4 channels have been associated with cartilage development [24],

Fig. 6. ATP release during HS is reduced following IGF-1 treatment and inhibition of TRPV channels. A) After 5 min of HS, ATP release was 12 times higher
than static controls. IGF-1 treatment attenuated the release of ATP and was only 3 times greater than static controls. B) Inhibition of TRPV channels reduced ATP
release during HS (HS + RR), and inhibition of TRPV4 (HS + RN) specifically reduced ATP by the same degree. (* indicates a p-value < 0.05 compared to controls).
8
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Importantly autologous implantation of chondrocytes overexpressing
IGF-1 significantly improves collagen production, glycosaminoglycan,
and mechanical properties of articular cartilage in equine PTOA models
[47,48]. Although the mechanism by which IGF-1 alters actin poly
merization is relatively unclear, Novakofski et al. have shown that IGF-1
suppresses RhoA GTPase activation in chondrocytes, while increasing
cortical F-actin staining below the plasma membrane [18]. We show
that IGF-1 stiffens ATDC5 cells via stimulation of F-actin. This increase
in cell stiffness then reduces the deformation of the plasma membrane
under hypotonic conditions and the subsequent activation of the TRPV4
channel.
IGF-1 levels fluctuate with age, reaching peak concentrations of over
300 ng/ml by the age of 15, and decreasing to less than a third of peak
concentrations by the age of 65 [63]. Currently, few studies utilize IGF-1
concentrations above physiologic concentrations of 600 ng/ml in their
experiments and some evidence suggests that chondrocytes differen
tially respond to IGF-1 administration. Phornphutkul et al. observed that
10 nM of IGF-1 treatment increased chondrocyte differentiation and
proteoglycan production, while administration of 50 nM of IGF-1 pro
moted chondrocyte proliferation [64]. In our studies, we observed that
IGF-1 attenuates the TRPV4 mediated response to osmotic stimuli
starting at concentrations of 100 ng/ml and maximally suppresses
chondrocyte osmosensation at 300 ng/ml. Contrary to our findings, Lee
et al. show that IGF-1 sensitized TRPV4 activity through SGK1 phos
phorylation of the serine 824 amino acid of TRPV4 in HEK293 cells [48].
However, Lee et al. did not challenge the HEK293 cells with HS and it is
unclear if 100 µM or 1 µM of IGF-1 were utilized in these studies, due to
differences reported in the concentrations of IGF-1 used between the
results section and the figure legend of the paper. These results suggest
that supraphysiologic concentrations of IGF-1 may sensitize TRPV4 but
it remains unknown how these concentrations influence cells and, spe
cifically, chondrocyte mechanotransduction. Thus, future studies may
elucidate if there is a biphasic response in TRPV4 mediated mechano
transduction during IGF-1 treatment.
We have previously reported that ATP release from osteoblasts is
dependent on calcium entry into the cell [54]. Thus, reducing the Ca2+
entry through the TRPV4 channel by IGF-1 could also impact ATP
release in response to mechanical loading in chondrocytes. In this study,
we highlight the link between IGF-1 regulation of TRPV4 and how it
reduces extracellular ATP release from chondrocytes. This inhibition of
extracellular ATP release appears to be mediated through the interaction
of actin and TRPV4. While chondrocytes release ATP in response to
mechanical stimuli to promote chondrogenesis, elevated levels of ATP
have been found in the synovial fluid of patients with chondrocalcinosis
and OA [55]. This indicates that differential responses to extracellular
ATP in chondrocytes may be influenced by the pathological status of
cartilage. With the loss of IGF-1 seen in OA patients, mechanical loading
of chondrocytes may lead to excessive ATP release. Additionally,
depletion of ATP in chondrocytes has previously been reported in
spontaneous OA in Hartley Guinea Pigs [56] and exogenous adenosine
administration reverses this disease state [57]. Ultimately, insensitivity
to IGF-1 observed in OA patients may promote excessive ATP release
during mechanical loading, leading to the depleted ATP status observed
in OA.
Our study emphasizes IGF-1 as a promising candidate for the pre
vention and treatment of articular cartilage damage during aging and
OA. Our data elucidate a potentially important mechanism by which
IGF-1 regulates chondrocyte mechanosensitivity, a major contributor to
articular chondrocyte function. This mechanism involves the coordi
nated control of actin organization, cell stiffness, TRPV4 mediated cal
cium flux and ATP release. However, because mechanical signals
regulate both anabolic and catabolic chondrocyte functions, future
studies are needed to define the relationship between this regulatory
pathway and chondrocyte anabolic and catabolic activities.
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